1. Diarylpyrazole Ligated Dihydropyrimidine Hybrids as Potent Non-Classical Antifolates and Their Efficacy Against Plasmodium falciparum.
- Author
-
Bhatt JD, Chudasama CJ, and Patel KD
- Subjects
- Animals, Antimalarials pharmacokinetics, Chlorocebus aethiops, Folic Acid Antagonists pharmacokinetics, Humans, Malaria, Falciparum parasitology, Models, Molecular, Pyrimidines pharmacokinetics, Pyrimidines pharmacology, Structure-Activity Relationship, Vero Cells, Antimalarials chemical synthesis, Antimalarials pharmacology, Folic Acid Antagonists chemical synthesis, Folic Acid Antagonists pharmacology, Malaria, Falciparum drug therapy, Plasmodium falciparum drug effects, Pyrazoles chemistry, Pyrimidines chemistry
- Abstract
A series of diarylpyrazole clubbed dihydropyrimidine derivatives (J1-J30) was synthesized under microwave-assisted heating conditions by employing Biginelli reaction methodology and utilizing triethylammonium acetate both as a catalyst and as reaction medium, leading towards a greener reaction pathway. The synthesized entities were screened for their antimalarial efficacy against a Plasmodium falciparum strain in vitro. The active entities (J9, J15, J21, J25, and J27) obtained out of the in vitro screening were further evaluated for their enzyme inhibitory potency against the Pf-DHFR enzyme in vitro as well as in silico using Glide. Furthermore, the active scaffolds were tested for their cytotoxicity against Vero cells, proving their nontoxic behavior and selectivity. The ADME parameters were also evaluated and predicted in silico, indicating good oral bioavailability of the compounds., (© 2017 Deutsche Pharmazeutische Gesellschaft.)
- Published
- 2017
- Full Text
- View/download PDF